Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX)
$2.5800
+0.3300 ( +15.70% ) 123.1K
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derivedĀ from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
Market Data
Open
$2.5800
Previous close
$2.2500
Volume
123.1K
Market cap
$31.91M
Day range
$2.1750 - $2.5800
52 week range
$1.0400 - $3.0500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Mar 26, 2024 |
4 | Insider transactions | 1 | Mar 26, 2024 |
4 | Insider transactions | 1 | Mar 26, 2024 |
4 | Insider transactions | 1 | Mar 26, 2024 |
4 | Insider transactions | 1 | Mar 26, 2024 |
4 | Insider transactions | 1 | Mar 26, 2024 |
ars | Annual reports | 1 | Mar 22, 2024 |
8-k | 8K-related | 19 | Mar 20, 2024 |
10-k | Annual reports | 114 | Mar 13, 2024 |
def | Proxies and info statements | 6 | Mar 13, 2024 |